December 1, 2014 (Vol. 34, No. 21) Yes, many are attracted to next-generation sequencing, but loyalty to chip-based phenotyping has its rewards, particularly in screens of large sample sets.

April 8, 2013 Ingenuity Systems and Affymetrix will be co-promoting Ingenuity® iReport™ with Affymetrix’ expression microarray products to help eliminate a bottleneck for researchers working ...

The pact comes after Santa Clara, CA-based Affymetrix, an early mover in the gene chip business, saw its revenues decline because of heavy competition in the gene expression microarray business ...

Custom Chip Design The AmpliChip Leukemia research microarray was specifically customized for the classification of leukemias. 20 The chip contained 1,480 distinct probe sets with 11-μm feature size.

A U.S. patent appeals court ruled on Thursday in favor of Agilent Technologies <A.N>, which had been involved in a patent fight with Affymetrix Inc <AFFX.O>.

The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing.

The widely-used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing.

Pharmaceutical and diagnostic giant Roche agreed to buy Madison, Wis.-based NimbleGen Systems, a developer of chips that analyze gene activity and variation, for $272.5 million. (The release is here.) ...